Global and United States Proto-Oncogene Drgu Market Insights, Forecast to 2027
SKU ID : QYR-18789324 | Publishing Date : 23-Jul-2021 | No. of pages : 140
Detailed TOC of Global and United States Proto-Oncogene Drgu Market Insights, Forecast to 2027
1 Study Coverage1.1 Proto-Oncogene Drgu Product Introduction
1.2 Market by Type
1.2.1 Global Proto-Oncogene Drgu Market Size Growth Rate by Type
1.2.2 Axitinib (Inlyta)
1.2.3 Ponatinib (Iclusig)
1.2.4 Imatinib (Gleevec)
1.2.5 Sunitinib (Sutent)
1.2.6 Pazopanib (Votrient)
1.2.7 Dabrafenib (Tafinlar)
1.2.8 Vandetanib (Caprelsa)
1.2.9 Vemurafenib (Zelboraf)
1.2.10 Cabozantinib (Cabometyx and Cometriq)
1.2.11 Sorafenib (Nexavar)
1.3 Market by Application
1.3.1 Global Proto-Oncogene Drgu Market Size Growth Rate by Application
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Proto-Oncogene Drgu Market Size, Estimates and Forecasts
2.1.1 Global Proto-Oncogene Drgu Revenue 2016-2027
2.1.2 Global Proto-Oncogene Drgu Sales 2016-2027
2.2 Global Proto-Oncogene Drgu, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Proto-Oncogene Drgu Historical Market Size by Region (2016-2021)
2.3.1 Global Proto-Oncogene Drgu Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Proto-Oncogene Drgu Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Proto-Oncogene Drgu Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Proto-Oncogene Drgu Sales Forecast by Region (2022-2027)
2.4.2 Global Proto-Oncogene Drgu Revenue Forecast by Region (2022-2027)
3 Global Proto-Oncogene Drgu Competitor Landscape by Players
3.1 Global Top Proto-Oncogene Drgu Manufacturers by Sales
3.1.1 Global Proto-Oncogene Drgu Sales by Manufacturer (2016-2021)
3.1.2 Global Proto-Oncogene Drgu Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Proto-Oncogene Drgu Manufacturers by Revenue
3.2.1 Key Proto-Oncogene Drgu Manufacturers Covered: Ranking by Revenue
3.2.2 Global Proto-Oncogene Drgu Revenue by Manufacturers (2016-2021)
3.2.3 Global Proto-Oncogene Drgu Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Proto-Oncogene Drgu Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Proto-Oncogene Drgu Revenue in 2020
3.2.6 Global Proto-Oncogene Drgu Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Proto-Oncogene Drgu Price by Manufacturers
3.4 Global Proto-Oncogene Drgu Manufacturing Base Distribution, Product Types
3.4.1 Proto-Oncogene Drgu Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Proto-Oncogene Drgu Product Type
3.4.3 Date of International Manufacturers Enter into Proto-Oncogene Drgu Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Proto-Oncogene Drgu Market Size by Type (2016-2021)
4.1.1 Global Proto-Oncogene Drgu Sales by Type (2016-2021)
4.1.2 Global Proto-Oncogene Drgu Revenue by Type (2016-2021)
4.1.3 Proto-Oncogene Drgu Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Proto-Oncogene Drgu Market Size Forecast by Type (2022-2027)
4.2.1 Global Proto-Oncogene Drgu Sales Forecast by Type (2022-2027)
4.2.2 Global Proto-Oncogene Drgu Revenue Forecast by Type (2022-2027)
4.2.3 Proto-Oncogene Drgu Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Proto-Oncogene Drgu Market Size by Application (2016-2021)
5.1.1 Global Proto-Oncogene Drgu Sales by Application (2016-2021)
5.1.2 Global Proto-Oncogene Drgu Revenue by Application (2016-2021)
5.1.3 Proto-Oncogene Drgu Price by Application (2016-2021)
5.2 Proto-Oncogene Drgu Market Size Forecast by Application (2022-2027)
5.2.1 Global Proto-Oncogene Drgu Sales Forecast by Application (2022-2027)
5.2.2 Global Proto-Oncogene Drgu Revenue Forecast by Application (2022-2027)
5.2.3 Global Proto-Oncogene Drgu Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Proto-Oncogene Drgu Market Size YoY Growth 2016-2027
6.1.1 United States Proto-Oncogene Drgu Sales YoY Growth 2016-2027
6.1.2 United States Proto-Oncogene Drgu Revenue YoY Growth 2016-2027
6.1.3 United States Proto-Oncogene Drgu Market Share in Global Market 2016-2027
6.2 United States Proto-Oncogene Drgu Market Size by Players (International and Local Players)
6.2.1 United States Top Proto-Oncogene Drgu Players by Sales (2016-2021)
6.2.2 United States Top Proto-Oncogene Drgu Players by Revenue (2016-2021)
6.3 United States Proto-Oncogene Drgu Historic Market Review by Type (2016-2021)
6.3.1 United States Proto-Oncogene Drgu Sales Market Share by Type (2016-2021)
6.3.2 United States Proto-Oncogene Drgu Revenue Market Share by Type (2016-2021)
6.3.3 United States Proto-Oncogene Drgu Price by Type (2016-2021)
6.4 United States Proto-Oncogene Drgu Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Proto-Oncogene Drgu Sales Forecast by Type (2022-2027)
6.4.2 United States Proto-Oncogene Drgu Revenue Forecast by Type (2022-2027)
6.4.3 United States Proto-Oncogene Drgu Price Forecast by Type (2022-2027)
6.5 United States Proto-Oncogene Drgu Historic Market Review by Application (2016-2021)
6.5.1 United States Proto-Oncogene Drgu Sales Market Share by Application (2016-2021)
6.5.2 United States Proto-Oncogene Drgu Revenue Market Share by Application (2016-2021)
6.5.3 United States Proto-Oncogene Drgu Price by Application (2016-2021)
6.6 United States Proto-Oncogene Drgu Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Proto-Oncogene Drgu Sales Forecast by Application (2022-2027)
6.6.2 United States Proto-Oncogene Drgu Revenue Forecast by Application (2022-2027)
6.6.3 United States Proto-Oncogene Drgu Price Forecast by Application (2022-2027)
7 North America
7.1 North America Proto-Oncogene Drgu Market Size YoY Growth 2016-2027
7.2 North America Proto-Oncogene Drgu Market Facts & Figures by Country
7.2.1 North America Proto-Oncogene Drgu Sales by Country (2016-2021)
7.2.2 North America Proto-Oncogene Drgu Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Proto-Oncogene Drgu Market Size YoY Growth 2016-2027
8.2 Asia Pacific Proto-Oncogene Drgu Market Facts & Figures by Region
8.2.1 Asia Pacific Proto-Oncogene Drgu Sales by Region (2016-2021)
8.2.2 Asia Pacific Proto-Oncogene Drgu Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Proto-Oncogene Drgu Market Size YoY Growth 2016-2027
9.2 Europe Proto-Oncogene Drgu Market Facts & Figures by Country
9.2.1 Europe Proto-Oncogene Drgu Sales by Country (2016-2021)
9.2.2 Europe Proto-Oncogene Drgu Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Proto-Oncogene Drgu Market Size YoY Growth 2016-2027
10.2 Latin America Proto-Oncogene Drgu Market Facts & Figures by Country
10.2.1 Latin America Proto-Oncogene Drgu Sales by Country (2016-2021)
10.2.2 Latin America Proto-Oncogene Drgu Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Proto-Oncogene Drgu Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Proto-Oncogene Drgu Market Facts & Figures by Country
11.2.1 Middle East and Africa Proto-Oncogene Drgu Sales by Country (2016-2021)
11.2.2 Middle East and Africa Proto-Oncogene Drgu Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 ARIAD Pharmaceuticals
12.1.1 ARIAD Pharmaceuticals Corporation Information
12.1.2 ARIAD Pharmaceuticals Description and Business Overview
12.1.3 ARIAD Pharmaceuticals Proto-Oncogene Drgu Sales, Revenue and Gross Margin (2016-2021)
12.1.4 ARIAD Pharmaceuticals Proto-Oncogene Drgu Products Offered
12.1.5 ARIAD Pharmaceuticals Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Corporation Information
12.2.2 AstraZeneca Description and Business Overview
12.2.3 AstraZeneca Proto-Oncogene Drgu Sales, Revenue and Gross Margin (2016-2021)
12.2.4 AstraZeneca Proto-Oncogene Drgu Products Offered
12.2.5 AstraZeneca Recent Development
12.3 Bayer Healthcare
12.3.1 Bayer Healthcare Corporation Information
12.3.2 Bayer Healthcare Description and Business Overview
12.3.3 Bayer Healthcare Proto-Oncogene Drgu Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Bayer Healthcare Proto-Oncogene Drgu Products Offered
12.3.5 Bayer Healthcare Recent Development
12.4 Bristol-Myers Squibb
12.4.1 Bristol-Myers Squibb Corporation Information
12.4.2 Bristol-Myers Squibb Description and Business Overview
12.4.3 Bristol-Myers Squibb Proto-Oncogene Drgu Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Bristol-Myers Squibb Proto-Oncogene Drgu Products Offered
12.4.5 Bristol-Myers Squibb Recent Development
12.5 ChemGenex Pharmaceuticals
12.5.1 ChemGenex Pharmaceuticals Corporation Information
12.5.2 ChemGenex Pharmaceuticals Description and Business Overview
12.5.3 ChemGenex Pharmaceuticals Proto-Oncogene Drgu Sales, Revenue and Gross Margin (2016-2021)
12.5.4 ChemGenex Pharmaceuticals Proto-Oncogene Drgu Products Offered
12.5.5 ChemGenex Pharmaceuticals Recent Development
12.6 Dexa Medica
12.6.1 Dexa Medica Corporation Information
12.6.2 Dexa Medica Description and Business Overview
12.6.3 Dexa Medica Proto-Oncogene Drgu Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Dexa Medica Proto-Oncogene Drgu Products Offered
12.6.5 Dexa Medica Recent Development
12.7 Eisai Pharmaceuticals
12.7.1 Eisai Pharmaceuticals Corporation Information
12.7.2 Eisai Pharmaceuticals Description and Business Overview
12.7.3 Eisai Pharmaceuticals Proto-Oncogene Drgu Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Eisai Pharmaceuticals Proto-Oncogene Drgu Products Offered
12.7.5 Eisai Pharmaceuticals Recent Development
12.8 Exelixis
12.8.1 Exelixis Corporation Information
12.8.2 Exelixis Description and Business Overview
12.8.3 Exelixis Proto-Oncogene Drgu Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Exelixis Proto-Oncogene Drgu Products Offered
12.8.5 Exelixis Recent Development
12.9 GlaxoSmithKline
12.9.1 GlaxoSmithKline Corporation Information
12.9.2 GlaxoSmithKline Description and Business Overview
12.9.3 GlaxoSmithKline Proto-Oncogene Drgu Sales, Revenue and Gross Margin (2016-2021)
12.9.4 GlaxoSmithKline Proto-Oncogene Drgu Products Offered
12.9.5 GlaxoSmithKline Recent Development
12.10 Novartis
12.10.1 Novartis Corporation Information
12.10.2 Novartis Description and Business Overview
12.10.3 Novartis Proto-Oncogene Drgu Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Novartis Proto-Oncogene Drgu Products Offered
12.10.5 Novartis Recent Development
12.11 ARIAD Pharmaceuticals
12.11.1 ARIAD Pharmaceuticals Corporation Information
12.11.2 ARIAD Pharmaceuticals Description and Business Overview
12.11.3 ARIAD Pharmaceuticals Proto-Oncogene Drgu Sales, Revenue and Gross Margin (2016-2021)
12.11.4 ARIAD Pharmaceuticals Proto-Oncogene Drgu Products Offered
12.11.5 ARIAD Pharmaceuticals Recent Development
12.12 Plexxikon
12.12.1 Plexxikon Corporation Information
12.12.2 Plexxikon Description and Business Overview
12.12.3 Plexxikon Proto-Oncogene Drgu Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Plexxikon Products Offered
12.12.5 Plexxikon Recent Development
12.13 Pfizer
12.13.1 Pfizer Corporation Information
12.13.2 Pfizer Description and Business Overview
12.13.3 Pfizer Proto-Oncogene Drgu Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Pfizer Products Offered
12.13.5 Pfizer Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Proto-Oncogene Drgu Industry Trends
13.2 Proto-Oncogene Drgu Market Drivers
13.3 Proto-Oncogene Drgu Market Challenges
13.4 Proto-Oncogene Drgu Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Proto-Oncogene Drgu Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and United States Proto-Oncogene Drgu Market Insights, Forecast to 2027
List of TablesTable 1. Global Proto-Oncogene Drgu Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Axitinib (Inlyta)
Table 3. Major Manufacturers of Ponatinib (Iclusig)
Table 4. Major Manufacturers of Imatinib (Gleevec)
Table 5. Major Manufacturers of Sunitinib (Sutent)
Table 6. Major Manufacturers of Pazopanib (Votrient)
Table 7. Major Manufacturers of Dabrafenib (Tafinlar)
Table 8. Major Manufacturers of Vandetanib (Caprelsa)
Table 9. Major Manufacturers of Vemurafenib (Zelboraf)
Table 10. Major Manufacturers of Cabozantinib (Cabometyx and Cometriq)
Table 11. Major Manufacturers of Sorafenib (Nexavar)
Table 12. Global Proto-Oncogene Drgu Market Size Growth Rate by Application (2021-2027) & (K Pcs)
Table 13. Global Proto-Oncogene Drgu Market Size by Region (K Pcs) & (US$ Million), 2016 VS 2021 VS 2027
Table 14. Global Proto-Oncogene Drgu Sales by Regions (2016-2021) & (K Pcs)
Table 15. Global Proto-Oncogene Drgu Sales Market Share by Regions (2016-2021)
Table 16. Global Proto-Oncogene Drgu Revenue by Regions (2016-2021) & (US$ Million)
Table 17. Global Proto-Oncogene Drgu Sales Forecast by Region (2022-2027) & (K Pcs)
Table 18. Global Proto-Oncogene Drgu Sales Market Share Forecast by Region (2022-2027)
Table 19. Global Proto-Oncogene Drgu Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 20. Global Proto-Oncogene Drgu Revenue Market Share Forecast by Region (2022-2027)
Table 21. Global Proto-Oncogene Drgu Sales by Manufacturers (2016-2021) (K Pcs)
Table 22. Global Proto-Oncogene Drgu Sales Share by Manufacturers (2016-2021)
Table 23. Ranking of Global Top Proto-Oncogene Drgu Manufacturers by Revenue (US$ Million) in 2020
Table 24. Proto-Oncogene Drgu Revenue by Manufacturers (2016-2021) (US$ Million)
Table 25. Proto-Oncogene Drgu Revenue Share by Manufacturers (2016-2021)
Table 26. Global Proto-Oncogene Drgu Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 27. Global Proto-Oncogene Drgu by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Proto-Oncogene Drgu as of 2020)
Table 28. Key Manufacturers Proto-Oncogene Drgu Price (2016-2021) (USD/Pcs)
Table 29. Proto-Oncogene Drgu Manufacturers Manufacturing Base Distribution and Headquarters
Table 30. Manufacturers Proto-Oncogene Drgu Product Type
Table 31. Date of International Manufacturers Enter into Proto-Oncogene Drgu Market
Table 32. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 33. Global Proto-Oncogene Drgu Sales by Type (2016-2021) (K Pcs)
Table 34. Global Proto-Oncogene Drgu Sales Share by Type (2016-2021)
Table 35. Global Proto-Oncogene Drgu Revenue by Type (2016-2021) (US$ Million)
Table 36. Global Proto-Oncogene Drgu Revenue Share by Type (2016-2021)
Table 37. Proto-Oncogene Drgu Average Selling Price (ASP) by Type (2016-2021) & (USD/Pcs)
Table 38. Global Proto-Oncogene Drgu Sales Forecast by Type (2022-2027) & (K Pcs)
Table 39. Global Proto-Oncogene Drgu Sales Market Share Forecast by Type (2022-2027)
Table 40. Global Proto-Oncogene Drgu Revenue Forecast V (2022-2027) & (US$ Million)
Table 41. Global Proto-Oncogene Drgu Revenue Market Share Forecast by Type (2022-2027)
Table 42. Global Proto-Oncogene Drgu Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Pcs)
Table 43. Global Proto-Oncogene Drgu Sales by Application (2016-2021) (K Pcs)
Table 44. Global Proto-Oncogene Drgu Sales Share by Application (2016-2021)
Table 45. Global Proto-Oncogene Drgu Revenue by Application (2016-2021) (US$ Million)
Table 46. Global Proto-Oncogene Drgu Revenue Share by Application (2016-2021)
Table 47. Proto-Oncogene Drgu Average Selling Price (ASP) by Application (2016-2021) & (USD/Pcs)
Table 48. Global Proto-Oncogene Drgu Sales Forecast by Application (2022-2027) & (K Pcs)
Table 49. Global Proto-Oncogene Drgu Sales Market Share Forecast by Application (2022-2027)
Table 50. Global Proto-Oncogene Drgu Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 51. Global Proto-Oncogene Drgu Revenue Market Share Forecast by Application (2022-2027)
Table 52. Global Proto-Oncogene Drgu Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Pcs)
Table 53. United States Proto-Oncogene Drgu Sales (K Pcs) of Key Companies (2016-2021)
Table 54. United States Proto-Oncogene Drgu Sales Share by Company (2016-2021)
Table 55. United States Proto-Oncogene Drgu Revenue (US$ Million) by Company (2016-2021)
Table 56. United States Proto-Oncogene Drgu Revenue Share by Company (2016-2021)
Table 57. United States Proto-Oncogene Drgu Sales (K Pcs) by Type (2016-2021)
Table 58. United States Proto-Oncogene Drgu Sales Share by Type (2016-2021)
Table 59. United States Proto-Oncogene Drgu Revenue (US$ Million) Market Share by Type (2016-2021)
Table 60. United States Proto-Oncogene Drgu Price (USD/Pcs) by Type (2016-2021)
Table 61. United States Proto-Oncogene Drgu Sales (K Pcs) by Type (2022-2027)
Table 62. United States Proto-Oncogene Drgu Sales Share by Type (2022-2027)
Table 63. United States Proto-Oncogene Drgu Revenue (US$ Million) Market Share by Type (2022-2027)
Table 64. United States Proto-Oncogene Drgu Revenue Share by Type (2022-2027)
Table 65. United States Proto-Oncogene Drgu Price (USD/Pcs) by Type (2022-2027)
Table 66. United States Proto-Oncogene Drgu Sales (K Pcs) by Application (2016-2021)
Table 67. United States Proto-Oncogene Drgu Sales Share by Application (2016-2021)
Table 68. United States Proto-Oncogene Drgu Revenue (US$ Million) Market Share by Application (2016-2021)
Table 69. United States Proto-Oncogene Drgu Price (USD/Pcs) by Application (2016-2021)
Table 70. United States Proto-Oncogene Drgu Sales (K Pcs) by Application (2022-2027)
Table 71. United States Proto-Oncogene Drgu Sales Share by Application (2022-2027)
Table 72. United States Proto-Oncogene Drgu Revenue (US$ Million) Market Share by Application (2022-2027)
Table 73. United States Proto-Oncogene Drgu Revenue Share by Application (2022-2027)
Table 74. United States Proto-Oncogene Drgu Price (USD/Pcs) by Application (2022-2027)
Table 75. North America Proto-Oncogene Drgu Sales by Country (2016-2021) & (K Pcs)
Table 76. North America Proto-Oncogene Drgu Sales Market Share by Country (2016-2021)
Table 77. North America Proto-Oncogene Drgu Revenue by Country (2016-2021) & (US$ Million)
Table 78. North America Proto-Oncogene Drgu Revenue Market Share by Country (2016-2021)
Table 79. Asia Pacific Proto-Oncogene Drgu Sales by Region (2016-2021) & (K Pcs)
Table 80. Asia Pacific Proto-Oncogene Drgu Sales Market Share by Region (2016-2021)
Table 81. Asia Pacific Proto-Oncogene Drgu Revenue by Region (2016-2021) & (US$ Million)
Table 82. Asia Pacific Proto-Oncogene Drgu Revenue Market Share by Region (2016-2021)
Table 83. Europe Proto-Oncogene Drgu Sales by Country (2016-2021) & (K Pcs)
Table 84. Europe Proto-Oncogene Drgu Sales Market Share by Country (2016-2021)
Table 85. Europe Proto-Oncogene Drgu Revenue by Country (2016-2021) & (US$ Million)
Table 86. Europe Proto-Oncogene Drgu Revenue Market Share by Country (2016-2021)
Table 87. Latin America Proto-Oncogene Drgu Sales by Country (2016-2021) & (K Pcs)
Table 88. Latin America Proto-Oncogene Drgu Sales Market Share by Country (2016-2021)
Table 89. Latin Americaa Proto-Oncogene Drgu Revenue by Country (2016-2021) & (US$ Million)
Table 90. Latin America Proto-Oncogene Drgu Revenue Market Share by Country (2016-2021)
Table 91. Middle East and Africa Proto-Oncogene Drgu Sales by Country (2016-2021) & (K Pcs)
Table 92. Middle East and Africa Proto-Oncogene Drgu Sales Market Share by Country (2016-2021)
Table 93. Middle East and Africa Proto-Oncogene Drgu Revenue by Country (2016-2021) & (US$ Million)
Table 94. Middle East and Africa Proto-Oncogene Drgu Revenue Market Share by Country (2016-2021)
Table 95. ARIAD Pharmaceuticals Corporation Information
Table 96. ARIAD Pharmaceuticals Description and Business Overview
Table 97. ARIAD Pharmaceuticals Proto-Oncogene Drgu Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 98. ARIAD Pharmaceuticals Proto-Oncogene Drgu Product
Table 99. ARIAD Pharmaceuticals Recent Development
Table 100. AstraZeneca Corporation Information
Table 101. AstraZeneca Description and Business Overview
Table 102. AstraZeneca Proto-Oncogene Drgu Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 103. AstraZeneca Product
Table 104. AstraZeneca Recent Development
Table 105. Bayer Healthcare Corporation Information
Table 106. Bayer Healthcare Description and Business Overview
Table 107. Bayer Healthcare Proto-Oncogene Drgu Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 108. Bayer Healthcare Product
Table 109. Bayer Healthcare Recent Development
Table 110. Bristol-Myers Squibb Corporation Information
Table 111. Bristol-Myers Squibb Description and Business Overview
Table 112. Bristol-Myers Squibb Proto-Oncogene Drgu Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Bristol-Myers Squibb Product
Table 114. Bristol-Myers Squibb Recent Development
Table 115. ChemGenex Pharmaceuticals Corporation Information
Table 116. ChemGenex Pharmaceuticals Description and Business Overview
Table 117. ChemGenex Pharmaceuticals Proto-Oncogene Drgu Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. ChemGenex Pharmaceuticals Product
Table 119. ChemGenex Pharmaceuticals Recent Development
Table 120. Dexa Medica Corporation Information
Table 121. Dexa Medica Description and Business Overview
Table 122. Dexa Medica Proto-Oncogene Drgu Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Dexa Medica Product
Table 124. Dexa Medica Recent Development
Table 125. Eisai Pharmaceuticals Corporation Information
Table 126. Eisai Pharmaceuticals Description and Business Overview
Table 127. Eisai Pharmaceuticals Proto-Oncogene Drgu Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Eisai Pharmaceuticals Product
Table 129. Eisai Pharmaceuticals Recent Development
Table 130. Exelixis Corporation Information
Table 131. Exelixis Description and Business Overview
Table 132. Exelixis Proto-Oncogene Drgu Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Exelixis Product
Table 134. Exelixis Recent Development
Table 135. GlaxoSmithKline Corporation Information
Table 136. GlaxoSmithKline Description and Business Overview
Table 137. GlaxoSmithKline Proto-Oncogene Drgu Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. GlaxoSmithKline Product
Table 139. GlaxoSmithKline Recent Development
Table 140. Novartis Corporation Information
Table 141. Novartis Description and Business Overview
Table 142. Novartis Proto-Oncogene Drgu Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Novartis Product
Table 144. Novartis Recent Development
Table 145. Onyx Pharmaceuticals Corporation Information
Table 146. Onyx Pharmaceuticals Description and Business Overview
Table 147. Onyx Pharmaceuticals Proto-Oncogene Drgu Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 148. Onyx Pharmaceuticals Product
Table 149. Onyx Pharmaceuticals Recent Development
Table 150. Plexxikon Corporation Information
Table 151. Plexxikon Description and Business Overview
Table 152. Plexxikon Proto-Oncogene Drgu Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 153. Plexxikon Product
Table 154. Plexxikon Recent Development
Table 155. Pfizer Corporation Information
Table 156. Pfizer Description and Business Overview
Table 157. Pfizer Proto-Oncogene Drgu Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. Pfizer Product
Table 159. Pfizer Recent Development
Table 160. Proto-Oncogene Drgu Market Trends
Table 161. Proto-Oncogene Drgu Market Drivers
Table 162. Proto-Oncogene Drgu Market Challenges
Table 163. Proto-Oncogene Drgu Market Restraints
Table 164. Proto-Oncogene Drgu Customers List
Table 165. Proto-Oncogene Drgu Distributors List
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Proto-Oncogene Drgu Product Picture
Figure 2. Global Proto-Oncogene Drgu Sales Market Share by Type in 2020 & 2027
Figure 3. Axitinib (Inlyta) Product Picture
Figure 4. Ponatinib (Iclusig) Product Picture
Figure 5. Imatinib (Gleevec) Product Picture
Figure 6. Sunitinib (Sutent) Product Picture
Figure 7. Pazopanib (Votrient) Product Picture
Figure 8. Dabrafenib (Tafinlar) Product Picture
Figure 9. Vandetanib (Caprelsa) Product Picture
Figure 10. Vemurafenib (Zelboraf) Product Picture
Figure 11. Cabozantinib (Cabometyx and Cometriq) Product Picture
Figure 12. Sorafenib (Nexavar) Product Picture
Figure 13. Global Proto-Oncogene Drgu Sales Market Share by Application in 2020 & 2027
Figure 14. Clinic
Figure 15. Hospital
Figure 16. Others
Figure 17. Proto-Oncogene Drgu Report Years Considered
Figure 18. Global Proto-Oncogene Drgu Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Proto-Oncogene Drgu Market Size 2016-2027 (US$ Million)
Figure 20. Global Proto-Oncogene Drgu Sales 2016-2027 (K Pcs)
Figure 21. Global Proto-Oncogene Drgu Market Size Market Share by Region: 2021 Versus 2027
Figure 22. Global Proto-Oncogene Drgu Sales Market Share by Region (2016-2021)
Figure 23. Global Proto-Oncogene Drgu Sales Market Share by Region in 2020
Figure 24. Global Proto-Oncogene Drgu Revenue Market Share by Region (2016-2021)
Figure 25. Global Proto-Oncogene Drgu Revenue Market Share by Region in 2020
Figure 26. Global Proto-Oncogene Drgu Sales Share by Manufacturer in 2020
Figure 27. The Top 10 and 5 Players Market Share by Proto-Oncogene Drgu Revenue in 2020
Figure 28. Proto-Oncogene Drgu Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Proto-Oncogene Drgu Sales Market Share by Type (2016-2021)
Figure 30. Global Proto-Oncogene Drgu Sales Market Share by Type in 2020
Figure 31. Global Proto-Oncogene Drgu Revenue Market Share by Type (2016-2021)
Figure 32. Global Proto-Oncogene Drgu Revenue Market Share by Type in 2020
Figure 33. Global Proto-Oncogene Drgu Sales Market Share by Application (2016-2021)
Figure 34. Global Proto-Oncogene Drgu Sales Market Share by Application in 2020
Figure 35. Global Proto-Oncogene Drgu Revenue Market Share by Application (2016-2021)
Figure 36. Global Proto-Oncogene Drgu Revenue Market Share by Application in 2020
Figure 37. United States Proto-Oncogene Drgu Sales Growth Rate 2016-2027 (K Pcs)
Figure 38. United States Proto-Oncogene Drgu Revenue Growth Rate 2016-2027 (US$ Million)
Figure 39. United States Proto-Oncogene Drgu Market Share in Global Market 2016-2027
Figure 40. United States 5 and 10 Largest Proto-Oncogene Drgu Players Market Share by Revenue in Proto-Oncogene Drgu in 2020
Figure 41. United States Proto-Oncogene Drgu Revenue Share by Type (2016-2021)
Figure 42. United States Proto-Oncogene Drgu Revenue Growth Rate by Type in 2016 & 2020
Figure 43. United States Proto-Oncogene Drgu Revenue Share by Application (2016-2021)
Figure 44. United States Proto-Oncogene Drgu Revenue Growth Rate by Application in 2016 & 2020
Figure 45. North America Proto-Oncogene Drgu Sales Growth Rate 2016-2021 (K Pcs)
Figure 46. North America Proto-Oncogene Drgu Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. North America Proto-Oncogene Drgu Sales Market Share by Country in 2020
Figure 48. North America Proto-Oncogene Drgu Revenue Market Share by Country in 2020
Figure 49. U.S. Proto-Oncogene Drgu Sales Growth Rate (2016-2021) (K Pcs)
Figure 50. U.S. Proto-Oncogene Drgu Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. Canada Proto-Oncogene Drgu Sales Growth Rate (2016-2021) (K Pcs)
Figure 52. Canada Proto-Oncogene Drgu Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. Europe Proto-Oncogene Drgu Sales Growth Rate 2016-2021 (K Pcs)
Figure 54. Europe Proto-Oncogene Drgu Revenue Growth Rate 2016-2021 (US$ Million)
Figure 55. Europe Proto-Oncogene Drgu Sales Market Share by Country in 2020
Figure 56. Europe Proto-Oncogene Drgu Revenue Market Share by Country in 2020
Figure 57. Germany Proto-Oncogene Drgu Sales Growth Rate (2016-2021) (K Pcs)
Figure 58. Germany Proto-Oncogene Drgu Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. France Proto-Oncogene Drgu Sales Growth Rate (2016-2021) (K Pcs)
Figure 60. France Proto-Oncogene Drgu Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. U.K. Proto-Oncogene Drgu Sales Growth Rate (2016-2021) (K Pcs)
Figure 62. U.K. Proto-Oncogene Drgu Revenue Growth Rate (2016-2021) (US$ Million)
Figure 63. Italy Proto-Oncogene Drgu Sales Growth Rate (2016-2021) (K Pcs)
Figure 64. Italy Proto-Oncogene Drgu Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Russia Proto-Oncogene Drgu Sales Growth Rate (2016-2021) (K Pcs)
Figure 66. Russia Proto-Oncogene Drgu Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Asia Pacific Proto-Oncogene Drgu Sales Growth Rate 2016-2021 (K Pcs)
Figure 68. Asia Pacific Proto-Oncogene Drgu Revenue Growth Rate 2016-2021 (US$ Million)
Figure 69. Asia Pacific Proto-Oncogene Drgu Sales Market Share by Region in 2020
Figure 70. Asia Pacific Proto-Oncogene Drgu Revenue Market Share by Region in 2020
Figure 71. China Proto-Oncogene Drgu Sales Growth Rate (2016-2021) (K Pcs)
Figure 72. China Proto-Oncogene Drgu Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Japan Proto-Oncogene Drgu Sales Growth Rate (2016-2021) (K Pcs)
Figure 74. Japan Proto-Oncogene Drgu Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. South Korea Proto-Oncogene Drgu Sales Growth Rate (2016-2021) (K Pcs)
Figure 76. South Korea Proto-Oncogene Drgu Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. India Proto-Oncogene Drgu Sales Growth Rate (2016-2021) (K Pcs)
Figure 78. India Proto-Oncogene Drgu Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Australia Proto-Oncogene Drgu Sales Growth Rate (2016-2021) (K Pcs)
Figure 80. Australia Proto-Oncogene Drgu Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Taiwan Proto-Oncogene Drgu Sales Growth Rate (2016-2021) (K Pcs)
Figure 82. Taiwan Proto-Oncogene Drgu Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Indonesia Proto-Oncogene Drgu Sales Growth Rate (2016-2021) (K Pcs)
Figure 84. Indonesia Proto-Oncogene Drgu Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Thailand Proto-Oncogene Drgu Sales Growth Rate (2016-2021) (K Pcs)
Figure 86. Thailand Proto-Oncogene Drgu Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Malaysia Proto-Oncogene Drgu Sales Growth Rate (2016-2021) (K Pcs)
Figure 88. Malaysia Proto-Oncogene Drgu Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Philippines Proto-Oncogene Drgu Sales Growth Rate (2016-2021) (K Pcs)
Figure 90. Philippines Proto-Oncogene Drgu Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Vietnam Proto-Oncogene Drgu Sales Growth Rate (2016-2021) (K Pcs)
Figure 92. Vietnam Proto-Oncogene Drgu Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Latin America Proto-Oncogene Drgu Sales Growth Rate 2016-2021 (K Pcs)
Figure 94. Latin America Proto-Oncogene Drgu Revenue Growth Rate 2016-2021 (US$ Million)
Figure 95. Latin America Proto-Oncogene Drgu Sales Market Share by Country in 2020
Figure 96. Latin America Proto-Oncogene Drgu Revenue Market Share by Country in 2020
Figure 97. Mexico Proto-Oncogene Drgu Sales Growth Rate (2016-2021) (K Pcs)
Figure 98. Mexico Proto-Oncogene Drgu Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. Brazil Proto-Oncogene Drgu Sales Growth Rate (2016-2021) (K Pcs)
Figure 100. Brazil Proto-Oncogene Drgu Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. Argentina Proto-Oncogene Drgu Sales Growth Rate (2016-2021) (K Pcs)
Figure 102. Argentina Proto-Oncogene Drgu Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. Middle East and Africa Proto-Oncogene Drgu Sales Growth Rate 2016-2021 (K Pcs)
Figure 104. Middle East and Africa Proto-Oncogene Drgu Revenue Growth Rate 2016-2021 (US$ Million)
Figure 105. Middle East and Africa Proto-Oncogene Drgu Sales Market Share by Country in 2020
Figure 106. Middle East and Africa Proto-Oncogene Drgu Revenue Market Share by Country in 2020
Figure 107. Turkey Proto-Oncogene Drgu Sales Growth Rate (2016-2021) (K Pcs)
Figure 108. Turkey Proto-Oncogene Drgu Revenue Growth Rate (2016-2021) (US$ Million)
Figure 109. Saudi Arabia Proto-Oncogene Drgu Sales Growth Rate (2016-2021) (K Pcs)
Figure 110. Saudi Arabia Proto-Oncogene Drgu Revenue Growth Rate (2016-2021) (US$ Million)
Figure 111. UAE Proto-Oncogene Drgu Sales Growth Rate (2016-2021) (K Pcs)
Figure 112. UAE Proto-Oncogene Drgu Revenue Growth Rate (2016-2021) (US$ Million)
Figure 113. Proto-Oncogene Drgu Value Chain
Figure 114. Channels of Distribution
Figure 115. Distributors Profiles
Figure 116. Bottom-up and Top-down Approaches for This Report
Figure 117. Data Triangulation
Figure 118. Key Executives Interviewed
Keyplayers in Global and United States Proto-Oncogene Drgu Market Insights, Forecast to 2027
ARIAD PharmaceuticalsAstraZeneca
Bayer Healthcare
Bristol-Myers Squibb
ChemGenex Pharmaceuticals
Dexa Medica
Eisai Pharmaceuticals
Exelixis
GlaxoSmithKline
Novartis
Onyx Pharmaceuticals
Plexxikon
Pfizer